Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
Atypical meningioma
Brain tumor
Chordoid meningioma
Global methylation profile
Prognosis
WHO grade
Journal
Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673
Informations de publication
Date de publication:
19 04 2022
19 04 2022
Historique:
received:
22
02
2022
accepted:
07
04
2022
entrez:
20
4
2022
pubmed:
21
4
2022
medline:
22
4
2022
Statut:
epublish
Résumé
Chordoid meningioma is a morphological variant of meningioma designated as WHO grade 2. However, the recurrence rates varied widely in different case series, and to date, a unifying molecular genetic signature has not been identified. Among 1897 meningiomas resected at our institution, we identified 12 primary chordoid meningiomas from 12 patients. Histologically, all 12 cases had predominant (> 50%) chordoid morphology. Ten were otherwise grade 1, and two were also atypical. We performed DNA global methylation profile, copy number variation analysis, and targeted next-generation sequencing on 11 chordoid meningiomas, and compared to those of 51 non-chordoid, mostly high grade meningiomas. The chordoid meningiomas demonstrated a unique methylation profile in tSNE, UMAP, and hierarchical heatmap clustering analyses of the most differentially methylated CpGs. The most common copy number variation in chordoid meningioma was loss of 1p (7/11, 64%). Three chordoid meningiomas had 2p loss, which was significantly higher than the non-chordoid control cohort (27% vs 7.2%, p = 0.035). 22q loss was only seen in the two cases with additional atypical histological features. Chordoid meningiomas were enriched in mutations in chromatin remodeling genes EP400 (8/11,73%) KMT2C (4/11, 36%) and KMT2D (4/11, 36%), and showed low or absent NF2, TERT, SMO, and AKT1 mutations. Prognosis wise, only one case recurred. This case had atypical histology and high-grade molecular features including truncating NF2 mutation, 1p, 8p, 10, 14, 22q loss, and homozygous deletion of CDKN2A/B. Progression free survival of chordoid, otherwise grade 1 meningioma was comparable to non-chordoid WHO grade 1 meningioma (p = 0.75), and significantly better than chordoid WHO grade 2 meningioma (p = 0.019). Conclusion: the chordoid histology alone may not justify a universal WHO grade 2 designation. Screening for additional atypical histological or molecular genetic features is recommended.
Identifiants
pubmed: 35440040
doi: 10.1186/s40478-022-01362-3
pii: 10.1186/s40478-022-01362-3
pmc: PMC9020042
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
56Informations de copyright
© 2022. The Author(s).
Références
J Neurooncol. 2006 Jul;78(3):263-9
pubmed: 16628477
Acta Pathol Jpn. 1977 Jul;27(4):557-66
pubmed: 910629
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
J Neurooncol. 2016 Jan;126(1):107-116
pubmed: 26409888
Cancers (Basel). 2020 Jan 17;12(1):
pubmed: 31963394
PLoS Comput Biol. 2016 Apr 21;12(4):e1004873
pubmed: 27100738
J Neurooncol. 2018 May;137(3):575-582
pubmed: 29380221
Acta Neuropathol. 1979 Dec;48(3):235-7
pubmed: 525263
Cancer. 1988 Jul 15;62(2):391-406
pubmed: 3383139
J Neurooncol. 2010 Dec;100(3):465-73
pubmed: 20454999
Exp Mol Pathol. 2015 Oct;99(2):354-9
pubmed: 26302177
Neuropathology. 2015 Apr;35(2):137-47
pubmed: 25378105
Genome Biol. 2011;12(4):R41
pubmed: 21527027
Indian J Pathol Microbiol. 2020 Apr-Jun;63(2):267-269
pubmed: 32317529
J Neuropathol Exp Neurol. 2021 Jan 1;80(1):96-100
pubmed: 33068394
Histopathology. 2013 Jun;62(7):1002-17
pubmed: 23617629
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Clin Epigenetics. 2020 Jan 10;12(1):10
pubmed: 31924266
Nat Commun. 2017 Feb 14;8:14433
pubmed: 28195122
J Neuropathol Exp Neurol. 1986 Mar;45(2):95-107
pubmed: 3005518
Acta Neuropathol. 2018 Dec;136(6):975-978
pubmed: 30382370
Neurol India. 2018 Jan-Feb;66(1):156-160
pubmed: 29322978
Lancet Oncol. 2017 May;18(5):682-694
pubmed: 28314689
Am J Surg Pathol. 2000 Jul;24(7):899-905
pubmed: 10895812
World Neurosurg. 2016 Sep;93:198-207
pubmed: 27060511
Acta Neuropathol. 1985;68(1):80-2
pubmed: 3931407
J Korean Neurosurg Soc. 2014 Sep;56(3):194-9
pubmed: 25368760
Development. 2016 Aug 15;143(16):2882-97
pubmed: 27531948
Methods Mol Biol. 2018;1741:31-51
pubmed: 29392688
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931